In vivo postprandial lipid partitioning in liver and skeletal muscle in prediabetic and diabetic rats

Diabetologia

Volumn 56, Issue 3, 2013, Pages 618-626

  Jonkers, R A M ^a   Van Loon, L J C ^b   Nicolay, K ^a   Prompers, J J ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Carbon 13; Insulin resistance; Intrahepatocellular lipids; Intramyocellular lipids; Lipid uptake; Magnetic resonance spectroscopy; Prediabetes; Type 2 diabetes; ZDF rat

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; IN VIVO STUDY; LIPID ANALYSIS; LIPID OXIDATION; LIPID STORAGE; LIPID TRANSPORT; MALE; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; POSTPRANDIAL PERIOD; PREDIABETIC STATE; RATS; RATS, ZUCKER;

EID: 84878355072     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2792-x     Document Type: Article

References (46)

1. 1H NMR spectroscopy study. Diabetologia 42:113-116
2. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-1606
3. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285:E906-E916
4. Ryysy L, Hakkinen AM, Goto T et al (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749-758
5. Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267-2277
6. Bell JA, Volpi E, Fujita S, Cadenas JG, Rasmussen BB (2006) Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA. Diabetologia 49:2144-2152
7. Bonen A, Parolin ML, Steinberg GR et al (2004) Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18:1144-1146
8. Hegarty BD, Cooney GJ, Kraegen EW, Furler SM (2002) Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51:1477-1484
9. Kelley DE, Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349-2356
10. Luiken JJ, Arumugam Y, Dyck DJ et al (2001) Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276:40567-40573
11. Moors CC, van der Zijl NJ, Diamant M, Blaak EE, Goossens GH (2012) Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism. Int J Obes (Lond) 36:709-717
12. Ravikumar B, Carey PE, Snaar JE et al (2005) Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 288:E789-E797
13. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ (2002) Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283:E187-E192
14. Turcotte LP, Swenberger JR, Zavitz Tucker M, Yee AJ (2001) Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats. Diabetes 50:1389-1396
15. van Hees AM, Jans A, Hul GB, Roche HM, Saris WH, Blaak EE (2011) Skeletal muscle fatty acid handling in insulin resistant men. Obesity 19:1350-1359
16. Capaldo B, Napoli R, Di Marino L, Picardi A, Riccardi G, Sacca L (1988) Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance. J Clin Endocrinol Metab 67:893-898
17. Gaster M, Rustan AC, Aas V, Beck-Nielsen H (2004) Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53:542-548
18. Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130-E1141
19. Labbe SM, Croteau E, Grenier-Larouche T et al (2011) Normal postprandial nonesterified fatty acid uptake in muscles despite increased circulating fatty acids in type 2 diabetes. Diabetes 60:408-415
20. Lopez-Soriano EJ, Carbo N, Argiles JM (1991) Lipid metabolism in the obese Zucker rat. Disposal of an oral [14C]triolein load and lipoprotein lipase activity. Biochem J 274:651-656
21. Bessesen DH, Rupp CL, Eckel RH (1995) Dietary fat is shunted away from oxidation, toward storage in obese Zucker rats. Obes Res 3:179-189
22. Blaak EE, Wagenmakers AJ (2002) The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects. Diabetes 51:784-789
23. Blaak EE, Wagenmakers AJ, Glatz JF et al (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146-E154
24. Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR (2005) Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists. Am J Physiol Endocrinol Metab 289:E151-E159
25. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50:2548-2554
26. Perreault L, Bergman BC, Hunerdosse DM, Eckel RH (2010) Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes. Obesity 18:2093-2100
27. Turpeinen AK, Takala TO, Nuutila P et al (1999) Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R, S)-[18 F]fluoro-6-thia- heptadecanoic acid. Diabetes 48:1245-1250
28. Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR (2003) Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol Endocrinol Metab 285:E354-E362
29. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA (2000) Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279:E1039-E1044
30. Muurling M, van den Hoek AM, Mensink RP et al (2004) Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance. J Lipid Res 45:9-16
31. Berk PD, Zhou SL, Kiang CL, Stump D, Bradbury M, Isola LM (1997) Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J Biol Chem 272:8830-8835
32. Adiels M, Taskinen MR, Packard C et al (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755-765
33. Bourgeois CS, Wiggins D, Hems R, Gibbons GF (1995) VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin. Am J Physiol Endocrinol Metab 269:E208-E215
34. Cohn JS, Patterson BW, Uffelman KD, Davignon J, Steiner G (2004) Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J Clin Endocrinol Metab 89:3949-3955
35. 13C] magnetic resonance spectroscopy. Magn Reson Med 68:997-1006
36. Clark JB, Palmer CJ, Shaw WN (1983) The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173:68-75
37. Etgen GJ, Oldham BA (2000) Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 49:684-688
38. Vanhamme L, van den Boogaart A, van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35-43
39. De Feyter HM, Schaart G, Hesselink MK, Schrauwen P, Nicolay K, Prompers JJ (2006) Regional variations in intramyocellular lipid concentration correlate with muscle fiber type distribution in rat tibialis anterior muscle. Magn Reson Med 56:19-25
40. De Feyter HM, Lenaers E, Houten SM et al (2008) Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes. FASEB J 22:3947-3955
41. Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201-1210
42. Lambert JE, Parks EJ (2012) Postprandial metabolism of meal triglyceride in humans. Biochim Biophys Acta 1821:721-726
43. Yost TJ, Froyd KK, Jensen DR, Eckel RH (1995) Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus. Metabolism 44:786-790
44. Bonen A, Campbell SE, Benton CR et al (2004) Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc 63:245-249
45. Chabowski A, Chatham JC, Tandon NN et al (2006) Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab 291:E675-E682
46. Keesey RE, Swiergiel AH, Corbett SW (1990) Contribution of spontaneous activity to daily energy expenditure of adult obese and lean Zucker rats. Physiol Behav 48:327-331